Literature DB >> 15871005

[The role of pelvic lymphadenectomy in clinically localised prostate cancer].

M Schumacher1, F C Burkhard, U E Studer.   

Abstract

Lymph node dissection remains the only reliable method for exact staging to date. Extended lymphadenectomy including tissue along the external iliac vein, the obturator fossa, and along the internal iliac vessels should be performed in all patients undergoing radical prostatectomy. There is an increasing amount of data suggesting that removal of all diseased nodes, which contain minimal metastatic disease, may have a positive impact on disease-free and, perhaps, on overall survival. Due to the relatively benign course of the disease, longer follow-up periods are still necessary to make a definitive statement.

Entities:  

Mesh:

Year:  2005        PMID: 15871005     DOI: 10.1007/s00120-005-0828-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  39 in total

1.  Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?

Authors:  Pia Bader; Fiona C Burkhard; Regula Markwalder; Urs E Studer
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

2.  Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer?

Authors:  Fiona C Burkhard; Martin Schumacher; George N Thalmann; Urs E Studer
Journal:  BJU Int       Date:  2005-02       Impact factor: 5.588

3.  Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients.

Authors:  O Mathiesen; J Carl; O Bonderup; J Panduro
Journal:  Acta Oncol       Date:  1990       Impact factor: 4.089

4.  Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques.

Authors:  N N Stone; R G Stock; P Unger
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

5.  The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.

Authors:  David S DiMarco; Horst Zincke; Thomas J Sebo; Jeffrey Slezak; Erik J Bergstralh; Michael L Blute
Journal:  J Urol       Date:  2005-04       Impact factor: 7.450

6.  For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.

Authors:  S Caplin; J P Cerottini; F T Bosman; M T Constanda; J C Givel
Journal:  Cancer       Date:  1998-08-15       Impact factor: 6.860

7.  Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases.

Authors:  Friedhelm Wawroschek; Harry Vogt; Hermann Wengenmair; Dorothea Weckermann; Michael Hamm; Mathias Keil; Gerhard Graf; Peter Heidenreich; Rolf Harzmann
Journal:  Urol Int       Date:  2003       Impact factor: 2.089

Review 8.  The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy.

Authors:  J S Wolf; M Cher; M Dall'era; J C Presti; H Hricak; P R Carroll
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

9.  Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.

Authors:  D L Bluestein; D G Bostwick; E J Bergstralh; J E Oesterling
Journal:  J Urol       Date:  1994-05       Impact factor: 7.450

10.  Prognostic factors in men with stage D1 prostate cancer: identification of patients less likely to have prolonged survival after radical prostatectomy.

Authors:  A R Sgrignoli; P C Walsh; G D Steinberg; M S Steiner; J I Epstein
Journal:  J Urol       Date:  1994-10       Impact factor: 7.450

View more
  1 in total

1.  Reduction in incidence of lymphocele following extraperitoneal radical prostatectomy and pelvic lymph node dissection by bilateral peritoneal fenestration.

Authors:  Jens-Uwe Stolzenburg; Johanna Wasserscheid; Robert Rabenalt; Minh Do; Thilo Schwalenberg; Alan McNeill; Costantinos Constantinides; Panagiotis Kallidonis; Roman Ganzer; Evangelos Liatsikos
Journal:  World J Urol       Date:  2008-09-07       Impact factor: 4.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.